199 related articles for article (PubMed ID: 37637423)
1. Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors.
Scott-Dennis M; Rafani FA; Yi Y; Perera T; Harwood CR; Guba W; Rufer AC; Grether U; Veprintsev DB; Sykes DA
Front Pharmacol; 2023; 14():1158091. PubMed ID: 37637423
[No Abstract] [Full Text] [Related]
2. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
[TBL] [Abstract][Full Text] [Related]
4. Can BRET-based biosensors be used to characterize G-protein mediated signaling pathways of an insect GPCR, the Schistocerca gregaria CRF-related diuretic hormone receptor?
Lismont E; Verbakel L; Vogel E; Corbisier J; Degroot GN; Verdonck R; Verlinden H; Marchal E; Springael JY; Vanden Broeck J
Insect Biochem Mol Biol; 2020 Jul; 122():103392. PubMed ID: 32387240
[TBL] [Abstract][Full Text] [Related]
5. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
6. Gα
Finlay DB; Cawston EE; Grimsey NL; Hunter MR; Korde A; Vemuri VK; Makriyannis A; Glass M
Br J Pharmacol; 2017 Aug; 174(15):2545-2562. PubMed ID: 28516479
[TBL] [Abstract][Full Text] [Related]
7. A NanoBRET-Based H
Ma X; Gao M; Vischer HF; Leurs R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897787
[TBL] [Abstract][Full Text] [Related]
8. Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018.
Finlay DB; Nguyen T; Gamage TF; Chen S; Barrus DG; Patel PR; Thomas BF; Wiley JL; Zhang Y; Glass M
Pharmacol Res Perspect; 2022 Feb; 10(1):e00901. PubMed ID: 35041297
[TBL] [Abstract][Full Text] [Related]
9. Direct Coupling of a Seven-Transmembrane-Span Receptor to a Gαi G-Protein Regulatory Motif Complex.
Robichaux WG; Oner SS; Lanier SM; Blumer JB
Mol Pharmacol; 2015 Aug; 88(2):231-7. PubMed ID: 25972449
[TBL] [Abstract][Full Text] [Related]
10. Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through G
Barnett ME; Knapp BI; Bidlack JM
Mol Pharmacol; 2020 Oct; 98(4):462-474. PubMed ID: 32958572
[TBL] [Abstract][Full Text] [Related]
11. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
Eldeeb K; Leone-Kabler S; Howlett AC
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
[TBL] [Abstract][Full Text] [Related]
12. Galphai is not required for chemotaxis mediated by Gi-coupled receptors.
Neptune ER; Iiri T; Bourne HR
J Biol Chem; 1999 Jan; 274(5):2824-8. PubMed ID: 9915816
[TBL] [Abstract][Full Text] [Related]
13. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays.
Grafinger KE; Vandeputte MM; Cannaert A; Ametovski A; Sparkes E; Cairns E; Juchli PO; Haschimi B; Pulver B; Banister SD; Stove CP; Auwärter V
Drug Test Anal; 2021 Jul; 13(7):1412-1429. PubMed ID: 33908179
[TBL] [Abstract][Full Text] [Related]
14. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
[TBL] [Abstract][Full Text] [Related]
15. Detecting GPCR Signals With Optical Biosensors of Gα-GTP in Cell Lines and Primary Cell Cultures.
Janicot R; Park JC; Garcia-Marcos M
Curr Protoc; 2023 Jun; 3(6):e796. PubMed ID: 37310083
[TBL] [Abstract][Full Text] [Related]
16. Development of a Conformational Histamine H
Schihada H; Ma X; Zabel U; Vischer HF; Schulte G; Leurs R; Pockes S; Lohse MJ
ACS Sens; 2020 Jun; 5(6):1734-1742. PubMed ID: 32397705
[TBL] [Abstract][Full Text] [Related]
17. Live cell optical assay for precise characterization of receptors coupling to Gα12.
Masuho I; Skamangas NK; Martemyanov KA
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6(Suppl 6):88-95. PubMed ID: 30916867
[TBL] [Abstract][Full Text] [Related]
18. Fundamental features of receptor-mediated Gα
Odagaki Y; Kinoshita M; Javier Meana J; Callado LF; García-Sevilla JA
Brain Res; 2020 Nov; 1747():147032. PubMed ID: 32745659
[TBL] [Abstract][Full Text] [Related]
19. The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity.
Turu G; Simon A; Gyombolai P; Szidonya L; Bagdy G; Lenkei Z; Hunyady L
J Biol Chem; 2007 Mar; 282(11):7753-7. PubMed ID: 17227758
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
